News & Blogs » Antibody News » Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward at GenScript

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward at GenScript

Jul 26, 2018

GenScript is a leading contract research organization, with the mission of making research easy for researchers all over the globe. By providing completely custom generation platforms for therapeutic antibody discovery and reagent antibody development, GenScript is strong contributor in the fight against pollution, hunger, and disease. Would you like to learn more about GenScript's mission, mantra, and antibody services? Check out Technology Networks interview with GenScipt’s VP of Marketing Eric Wang.

In This Editorial You Will Learn

The Motivation Behind GenScript’ s Mission To Make Research Easy for Scientists Like You!
The Benefits of Using Rabbit Antibodies for Applications, Such as Basic Research and In-Vitro Diagnostics
How GenScript Therapeutic Antibody Discovery and Development Platform is Accelerating and Innovating Medicine

Click HERE To Read The Article in Technology Networks

MonoRab™; GenScript’s proprietary rabbit monoclonal antibody generation platform, is a full scale service including antigen preparation, rabbit immunization, recombinant antibody production, and antibody sequencing. Our proprietary hetero-hybridoma methodology includes an optimized fusion partner to improve overall fusion efficiency while utilizing the rabbit's natural ability to generate high specificity, high affinity mAb's against a wide range of difficult targets such as small molecules, Ab drugs, and even antigens non-immunogenic in mice.